Pheochromocytoma Concealed By Chronic Methamphetamine Abuse

ABSTRACT: Objective: Both clinical suspicion and diagnosis of pheochromocytoma (PCC) can be challenging in patients where the presentation can be confused with the pharmacophysiological effects of illicit drugs known to activate the sympathetic nervous system. We report on such a patient and outlin...

Full description

Bibliographic Details
Main Authors: Georgiana Constantinescu, MD, Steffen Leike, MD, Matthias Gruber, MD, Katharina Langton, MS, Carola Kunath, Mirko Peitzsch, PhD, Jaap Deinum, MD, PhD, Graeme Eisenhofer, PhD, Jacques Lenders, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520306118
_version_ 1818608154822311936
author Georgiana Constantinescu, MD
Steffen Leike, MD
Matthias Gruber, MD
Katharina Langton, MS
Carola Kunath
Mirko Peitzsch, PhD
Jaap Deinum, MD, PhD
Graeme Eisenhofer, PhD
Jacques Lenders, MD, PhD
author_facet Georgiana Constantinescu, MD
Steffen Leike, MD
Matthias Gruber, MD
Katharina Langton, MS
Carola Kunath
Mirko Peitzsch, PhD
Jaap Deinum, MD, PhD
Graeme Eisenhofer, PhD
Jacques Lenders, MD, PhD
author_sort Georgiana Constantinescu, MD
collection DOAJ
description ABSTRACT: Objective: Both clinical suspicion and diagnosis of pheochromocytoma (PCC) can be challenging in patients where the presentation can be confused with the pharmacophysiological effects of illicit drugs known to activate the sympathetic nervous system. We report on such a patient and outline considerations that can impact diagnostic decision making. Methods: Clinical examination, measurement of plasma metanephrines, followed by magnetic resonance imaging, iodine 123-metaiodobenzylguanidine single-photon emission computed tomography, and histopathology of the resected tumor. Results: A 35-year-old male patient was referred to our center because of a right-sided adrenal mass, incidentally found during an abdominal ultrasound performed due to nausea, vomiting, and lumbar pain. Although he had no history of hypertension, he had complained for over 6 years of severe episodic headache, panic attacks, and profuse sweating. He also had a longer history of methamphetamine abuse. Plasma concentrations of metanephrine (10.7 pmol/L) and normetanephrine (3.83 pmol/L) were 25-fold and 5.6-fold above respective upper limits of reference intervals (0.42 and 0.69 pmol/L). This indicated a PCC, which was confirmed after adrenalectomy. Failure to recognize the patient’s signs and symptoms as attributable to a PCC was unsurprising given that methamphetamine abuse can result in many of the same signs and symptoms as a catecholamine-producing tumor. Conclusion: The abuse of drugs such as methamphetamine can obscure an underlying PCC due to the similarity of several symptoms associated with both conditions. Recognition of a PCC in patients using illicit drugs such as methamphetamine remains challenging. Abbreviations: NE norepinephrine PCC pheochromocytoma
first_indexed 2024-12-16T14:38:08Z
format Article
id doaj.art-2e0abb6e9bf94ff7977c39dfd237135f
institution Directory Open Access Journal
issn 2376-0605
language English
last_indexed 2024-12-16T14:38:08Z
publishDate 2020-09-01
publisher Elsevier
record_format Article
series AACE Clinical Case Reports
spelling doaj.art-2e0abb6e9bf94ff7977c39dfd237135f2022-12-21T22:28:02ZengElsevierAACE Clinical Case Reports2376-06052020-09-0165e212e216Pheochromocytoma Concealed By Chronic Methamphetamine AbuseGeorgiana Constantinescu, MD0Steffen Leike, MD1Matthias Gruber, MD2Katharina Langton, MS3Carola Kunath4Mirko Peitzsch, PhD5Jaap Deinum, MD, PhD6Graeme Eisenhofer, PhD7Jacques Lenders, MD, PhD8Address correspondence to Dr. Georgiana Constantinescu, Department of Internal Medicine III, Technical University of Dresden, Fetscherstrasse 74, D-01307, Dresden, Germany.; From the Department of Endocrinology, Internal Medicine III, Dresden, GermanyDepartment of Urology, Dresden, GermanyFrom the Department of Endocrinology, Internal Medicine III, Dresden, GermanyInstitute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, GermanyInstitute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, GermanyInstitute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, GermanyFrom the Department of Endocrinology, Internal Medicine III, Dresden, Germany; the Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, GermanyFrom the Department of Endocrinology, Internal Medicine III, Dresden, Germany; the Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.ABSTRACT: Objective: Both clinical suspicion and diagnosis of pheochromocytoma (PCC) can be challenging in patients where the presentation can be confused with the pharmacophysiological effects of illicit drugs known to activate the sympathetic nervous system. We report on such a patient and outline considerations that can impact diagnostic decision making. Methods: Clinical examination, measurement of plasma metanephrines, followed by magnetic resonance imaging, iodine 123-metaiodobenzylguanidine single-photon emission computed tomography, and histopathology of the resected tumor. Results: A 35-year-old male patient was referred to our center because of a right-sided adrenal mass, incidentally found during an abdominal ultrasound performed due to nausea, vomiting, and lumbar pain. Although he had no history of hypertension, he had complained for over 6 years of severe episodic headache, panic attacks, and profuse sweating. He also had a longer history of methamphetamine abuse. Plasma concentrations of metanephrine (10.7 pmol/L) and normetanephrine (3.83 pmol/L) were 25-fold and 5.6-fold above respective upper limits of reference intervals (0.42 and 0.69 pmol/L). This indicated a PCC, which was confirmed after adrenalectomy. Failure to recognize the patient’s signs and symptoms as attributable to a PCC was unsurprising given that methamphetamine abuse can result in many of the same signs and symptoms as a catecholamine-producing tumor. Conclusion: The abuse of drugs such as methamphetamine can obscure an underlying PCC due to the similarity of several symptoms associated with both conditions. Recognition of a PCC in patients using illicit drugs such as methamphetamine remains challenging. Abbreviations: NE norepinephrine PCC pheochromocytomahttp://www.sciencedirect.com/science/article/pii/S2376060520306118
spellingShingle Georgiana Constantinescu, MD
Steffen Leike, MD
Matthias Gruber, MD
Katharina Langton, MS
Carola Kunath
Mirko Peitzsch, PhD
Jaap Deinum, MD, PhD
Graeme Eisenhofer, PhD
Jacques Lenders, MD, PhD
Pheochromocytoma Concealed By Chronic Methamphetamine Abuse
AACE Clinical Case Reports
title Pheochromocytoma Concealed By Chronic Methamphetamine Abuse
title_full Pheochromocytoma Concealed By Chronic Methamphetamine Abuse
title_fullStr Pheochromocytoma Concealed By Chronic Methamphetamine Abuse
title_full_unstemmed Pheochromocytoma Concealed By Chronic Methamphetamine Abuse
title_short Pheochromocytoma Concealed By Chronic Methamphetamine Abuse
title_sort pheochromocytoma concealed by chronic methamphetamine abuse
url http://www.sciencedirect.com/science/article/pii/S2376060520306118
work_keys_str_mv AT georgianaconstantinescumd pheochromocytomaconcealedbychronicmethamphetamineabuse
AT steffenleikemd pheochromocytomaconcealedbychronicmethamphetamineabuse
AT matthiasgrubermd pheochromocytomaconcealedbychronicmethamphetamineabuse
AT katharinalangtonms pheochromocytomaconcealedbychronicmethamphetamineabuse
AT carolakunath pheochromocytomaconcealedbychronicmethamphetamineabuse
AT mirkopeitzschphd pheochromocytomaconcealedbychronicmethamphetamineabuse
AT jaapdeinummdphd pheochromocytomaconcealedbychronicmethamphetamineabuse
AT graemeeisenhoferphd pheochromocytomaconcealedbychronicmethamphetamineabuse
AT jacqueslendersmdphd pheochromocytomaconcealedbychronicmethamphetamineabuse